Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity

v3.24.3
Shareholders' Equity
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Shareholders' Equity Shareholders' Equity
On December 20, 2022, the Board of Directors re-authorized the Company's share repurchase program. The previous share repurchase program had a term of 24 months and was set to expire on February 17, 2023. The share repurchase program allows for repurchase of up to 790,383 shares of the Company's outstanding common stock and extends to February 17, 2025. The shares will be purchased from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions. Under the program, the purchases will be funded from available working capital, and the repurchased shares will be returned to the status of authorized, but unissued shares of common stock or held in treasury. There is no guarantee as to the exact number of shares that will be repurchased by the Company and the Company may discontinue purchases at any time that management determines additional purchases are not warranted. As of September 30, 2024, the Company has 462,685 shares of its share repurchase authorization remaining.
Shares repurchased for the three and nine months ended September 30, 2024 and 2023 were as follows:
Three Months Ended
September 30,		 Nine Months Ended
September 30,
2024 2023 2024 2023
Number of shares repurchased 42,623  44,799  74,186  95,955 
Average price per share $ 9.79  $ 8.87  $ 9.92  $ 9.38 
Total cost of shares repurchased1
$ 418,563  $ 398,861  $ 738,361  $ 903,012 
1Includes broker commissions paid as part of repurchase transactions